Predictors of poor response to secondary alternative antiandrogen therapy with flutamide in metastatic castration-resistant prostate cancer.
暂无分享,去创建一个
M. Yao | Y. Miyoshi | H. Uemura | T. Kawahara | S. Yoneyama | M. Inoue | J. Teranishi | M. Yasui | Ko-ichi Uemura | Y. Hattori | J. Ohta | Y. Yokomizo | Koichi Uemura